Companies / Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc.
FNCHCIK 1733257
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 23, 2021 | Haft Nicholas Director | Buy Open-market buy | Common Stock | $15.00M | +882K | 882,351 | high |
| Mar 23, 2021 | Crestovo Investor LLC Director | Buy Open-market buy | Common Stock | $12.50M | +735K +6.18% | 12,641,441 | high |
| Mar 23, 2021 | Ferrante Domenic J Director | Buy Open-market buy | Common Stock | $1.75M | +103K +19.30% | 636,195 | high |
| Mar 23, 2021 | Smisek Jeffery a Director | Buy Open-market buy | Common Stock | $1.50M | +88K +5.49% | 1,694,541 | high |
| Dec 20, 2021 | Haft Nicholas Director | Buy Open-market buy | Common Stock, $0.001 par value per share | $650.0K | +64K +1.60% | 4,056,907 | high |
| Mar 28, 2024 | Smisek Jeffery a Director | Sell Open-market sale | Common Stock | $17.1K | -7K -100.00% | 0 | low |
| Nov 22, 2023 | Smisek Jeffery a Director | Sell Open-market sale | Common Stock | $5.4K | -1K -18.12% | 6,642 | low |
| Oct 21, 2022 | Blaustein Marc Executive | Sell Open-market sale | Common Stock | $5.1K | -4K -10.03% | 32,614 | low |